Canopy and RMCC: A Collaborative Leap in Cancer Care
On July 16, 2026, Canopy, a leading force in Enterprise AI for oncology, announced a strategic multi-year partnership with Rocky Mountain Cancer Centers (RMCC). RMCC, the largest multidisciplinary cancer care provider in Colorado, is dedicated to enhancing patient care and is poised to benefit significantly from this collaboration.
Revolutionizing Patient Care with AI
The partnership aims to integrate Canopy's advanced Enterprise AI platform into RMCC's patient services to improve operational efficiencies and modernize patient interactions. This transformation will manifest through various AI-enabled workflows, including secure communication channels and call center assistance, thus ensuring that patients can engage effectively with their healthcare teams.
Moreover, the technology will introduce remote therapeutic monitoring, allowing RMCC to enhance access to groundbreaking treatments such as bispecific therapies and CAR T-cell therapies, which have shown promise in treating complex cancer cases. The partnership underscores a commitment to provide comprehensive symptom management and continuous care, ultimately improving patients' experiences and treatment outcomes.
Empowering Care Teams With Automation
In addition to enhancing patient access, the partnership will streamline pharmacy processes through automation. By reducing tedious manual procedures, RMCC will improve adherence monitoring for oral cancer treatments and optimize refill management. This initiative is crucial as it allows healthcare professionals to focus on delivering personalized care, rather than getting bogged down in administrative tasks.
Dr. Manojkumar Bupathi, President of RMCC, emphasized the organization's dedication to providing the best possible care for patients close to their homes, stating, "With Canopy, we're investing in AI-native infrastructure that helps us stay at the forefront of this commitment."
The Role of AI in Modern Oncology
Canopy’s robust AI technology is designed to tackle the complexities of cancer care more efficiently. By integrating AI into existing workflows, RMCC can respond to patient needs more swiftly, reduce manual workloads, and establish sustainable reimbursement strategies. Notably, Canopy recently launched 'Kathy', an AI-driven call assistant tailored for oncology demands, operational at various practices to help during peak call times and after hours.
Lavi Kwiatkowsky, Founder and CEO of Canopy, expressed pride in collaborating with RMCC, highlighting their innovative approach to cancer care and commitment to advancing clinical trials and novel therapies. He reaffirmed Canopy's mission to leverage Enterprise AI to not only enhance patient experiences but also ease the complexities faced by care teams.
Clinical Evidence Supporting AI Integration
The partnership is further supported by compelling clinical evidence. Recent findings shared by Canopy at the 2026 ASCO Annual Meeting showed that patients utilizing the Canopy Remote Therapeutic Monitoring (RTM) platform experienced significant benefits. These included a
28% reduction in hospitalizations for metastatic solid tumors, translating into estimated annual savings of around
$3.2 million per 1,000 patients treated in a year.
Additionally, for patients undergoing immune checkpoint inhibitors, the RTM platform demonstrated an
82% increase in the median time before treatment discontinuation and a
51% decrease in hospitalization risk within 12 months, leading to an estimated annual savings of
$12.6 million per 1,000 person-years treated.
Conclusion
This groundbreaking partnership between Canopy and RMCC marks a significant step forward in healthcare innovation, particularly in oncology. By harnessing the power of AI, both organizations aim to redefine how cancer care is delivered, making it more efficient, patient-centric, and technologically advanced. As they embark on this journey together, the future of cancer care looks promising, with enhanced support for patients and healthcare professionals alike.
For more information about Canopy and RMCC, visit their respective websites at
www.canopycare.us and
www.rockymountaincancercenters.com.